Brief: Solid Biosciences Reports Additional Preclinical Data
17/10/2022 13:31
Oct 17 (Reuters) - Solid Biosciences Inc SLDB.O :
* SOLID BIOSCIENCES REPORTS ADDITIONAL PRECLINICAL DATA
DEMONSTRATING THAT ITS NOVEL CAPSID, AAV-SLB101, PROVIDES
SUPERIOR TRANSDUCTION EFFICIENCY AND ENHANCED DISTRIBUTION TO
SKELETAL MUSCLE
Source text for Eikon: ID:nGNXx82dD
Further company coverage: SLDB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solid Biosciences
See all newsMarketing Agreement To Advance Gene Therapy Delivery And Analytics
Solid Biosciences Q1 net loss widens on higher R&D costs
Solid Biosciences Q4 net loss widens on higher R&D costs
NASDAQ RESUMED AT 01:58 PM
Brief: Solid Biosciences Provides Interim Positive Clinical Update On Phase 1/2 Inspire Duchenne Trial